JEROME M DUBROFF
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease BROOKLYN, NY NPI 1407800147
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$883.55
- Category: General Payments
- Program years: PY2018–2023
- Record count: 26
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $268.11 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.11 | 6 |
| Education | $36.00 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $161.00 | 2 |
| PFIZER INC. | $45.04 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.54 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.07 | 1 |
| SHIELD THERAPEUTICS INC | $17.46 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1011687539 | AstraZeneca Pharmaceuticals LP | $125.00 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1016006615 | E.R. Squibb & Sons, L.L.C. | $21.07 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1045748481 | Shield Therapeutics Inc | $17.46 | 04/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1049217347 | PFIZER INC. | $20.92 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1050664233 | PFIZER INC. | $24.12 | 11/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1061178507 | AstraZeneca Pharmaceuticals LP | $36.00 | 12/05/2023 | Education | Undisputed | 01/23/2026 | View at CMS |
| 996998043 | Boehringer Ingelheim Pharmaceuticals, Inc. | $23.54 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.